ReachMD

Be part of the knowledge.™

Women’s Health Update

Pathology and Lab Medicine

290

LikeLikedUnlike

Episodes 1-15 of 64

- Jennifer Caudle, DO
  Peer
- Keith McCrae, MD
  Peer
- Terry B. Gernsheimer, MD
  Peer
0
Medical Industry Feature
Immune Thrombocytopenia: Updated Practice Guidelines in an Evolving Treatment Landscape
Immune Thrombocytopenia: Updated Practice Guidelines in an Evolving Treatment Landscape
- Jennifer W. Carlisle, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
2
CME/CE
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
0.50 credits
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
4
Medical Industry Feature
Advancements in Cervical Cancer & the Role of Biomarkers
Advancements in Cervical Cancer & the Role of Biomarkers
- Jeffrey S. Weber, MD, PhD
  Peer
3
CME/CE
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
0.25 credits
- Paul Doghramji, MD
  Peer
- Alex Spira, MD, PhD, FACP
  Peer
- John Longshore, PhD, FACMG
  Peer
1
Medical Industry Feature
Spotlight on KRAS G12C: Biomarker Testing Considerations in the NSCLC Landscape
Spotlight on KRAS G12C: Biomarker Testing Considerations in the NSCLC Landscape
- Robert Mocharnuk, MD
  Peer
- Pelin Cinar, MD, MS
  Peer
- Malika Fair, MD, MPH, FACEP
  Peer
6
CME/CE
The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities
The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities
1.00 credits
- Stephen Cohen, MD
  Peer
- Thomas C. Wright, Jr., MD
  Peer
11
CME/CE Broadcast Replay
Advances in Cervical Cancer Screening
Advances in Cervical Cancer Screening
0.50 credits
- Kevin Brown, MD
  Peer
- Kevin R. Flaherty, MD
  Peer
- Rebecca C. Keith, MD
  Peer
6
CME/CE Broadcast Replay
Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype
Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype
1.00 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
5
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
1.00 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
7
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
0.50 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
7
CME/CE
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
8
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
6
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
16
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Sara Hurvitz, MD
  Peer
- Jacob Sands, MD
  Peer
8
CME/CE
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
0.25 credits

Loading...

Programs 2/28/21

Segment Chapters

Playlist:

Recommended